Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royalty Pharma Collection Trust
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19533023Aexternal-prioritypatent/DE19533023B4/en
Application filed by Abbott GmbH and Co KGfiledCriticalAbbott GmbH and Co KG
Publication of AU3804595ApublicationCriticalpatent/AU3804595A/en
Publication of AU688611B2publicationCriticalpatent/AU688611B2/en
Assigned to ABBOTT GMBH & CO. KGreassignmentABBOTT GMBH & CO. KGAlteration of Name(s) in Register under S187Assignors: BASF AKTIENGESELLSCHAFT
Application grantedgrantedCritical
Publication of AU688611CpublicationCriticalpatent/AU688611C/en
Assigned to ABBVIE DEUTSCHLAND GMBH & CO KGreassignmentABBVIE DEUTSCHLAND GMBH & CO KGAlteration of Name(s) in Register under S187Assignors: ABBOTT GMBH & CO. KG
Assigned to ROYALTY PHARMA COLLECTION TRUSTreassignmentROYALTY PHARMA COLLECTION TRUSTAlteration of Name(s) in Register under S187Assignors: ABBVIE DEUTSCHLAND GMBH & CO KG
2-{(2-alkoxy-6-trifluoromethylpyrimidine-4-yl)-oxymethylene} -phenylacetic acid derivatives, their preparation and intermediates therefor, and use thereof